Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine versus lidocaine versus placebo for prevention of emergence agitation after rhinoplasty
IRCT20220302054164N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine and lidocaine in Emergence agitation (EA) and postoperative pain (3 arms), sponsored by Arak University of Medical Sciences. Primary endpoint: Restlessness when waking up from anesthesia. Started Apr 2022; status: completed.
02
Drugs
ketaminelidocaine
03
Conditions
Emergence agitation (EA)postoperative pain
Beyond the preview
Go deeper on IRCT20220302054164N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220302054164N1.